Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jude N. Owiredu"'
Autor:
Changmeng Cai, Timothy R. Rebbeck, Xin Yuan, Kellee R. Siegfried, Kourosh Zarringhalam, Jill A. Macoska, Mingyu Liu, Shuai Gao, Susan Patalano, Jocelyn S. Steinfeld, Maryam Labaf, Muqing Li, Bridget M. Healy, Jude N. Owiredu, Dong Han
Although American men of European ancestry represent the largest population of patients with prostate cancer, men of African ancestry are disproportionately affected by prostate cancer, with higher prevalence and worse outcomes. These racial disparit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd49e3504e33cb170b3ee891e2e6f7fa
https://doi.org/10.1158/0008-5472.c.6513216.v1
https://doi.org/10.1158/0008-5472.c.6513216.v1
Autor:
Changmeng Cai, Timothy R. Rebbeck, Xin Yuan, Kellee R. Siegfried, Kourosh Zarringhalam, Jill A. Macoska, Mingyu Liu, Shuai Gao, Susan Patalano, Jocelyn S. Steinfeld, Maryam Labaf, Muqing Li, Bridget M. Healy, Jude N. Owiredu, Dong Han
This document contains supplementary Figure 1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f4bc455fe248e92acd3096a128ec595
https://doi.org/10.1158/0008-5472.22429026
https://doi.org/10.1158/0008-5472.22429026
Autor:
Dong Han, Maryam Labaf, Changmeng Cai, Xin Yuan, Muqing Li, Kourosh Zarringhalam, Susan Patalano, Timothy R. Rebbeck, Shuai Gao, Mingyu Liu, Jill A. Macoska, Jocelyn S. Steinfeld, Kellee R. Siegfried, Bridget M. Healy, Jude N. Owiredu
Publikováno v:
Cancer Research. 81:3766-3776
Although American men of European ancestry represent the largest population of patients with prostate cancer, men of African ancestry are disproportionately affected by prostate cancer, with higher prevalence and worse outcomes. These racial disparit
Autor:
Dong, Han, Jude N, Owiredu, Bridget M, Healy, Muqing, Li, Maryam, Labaf, Jocelyn S, Steinfeld, Susan, Patalano, Shuai, Gao, Mingyu, Liu, Jill A, Macoska, Kourosh, Zarringhalam, Kellee R, Siegfried, Xin, Yuan, Timothy R, Rebbeck, Changmeng, Cai
Publikováno v:
Cancer research. 81(14)
Although American men of European ancestry represent the largest population of patients with prostate cancer, men of African ancestry are disproportionately affected by prostate cancer, with higher prevalence and worse outcomes. These racial disparit
Autor:
Changmeng Cai, Muqing Li, Sujun Chen, Wanting Han, Dong Han, Jude N. Owiredu, Housheng Hansen He, Steven P. Balk, Shuai Gao
Publikováno v:
Cancer research. 79(20)
Loss of expression of context-specific tumor suppressors is a critical event that facilitates the development of prostate cancer. Zinc finger and BTB domain containing transcriptional repressors, such as ZBTB7A and ZBTB16, have been recently identifi
Autor:
Changmeng Cai, Eric de Waal, Wanting Han, Shuai Gao, Jill A. Macoska, Dong Han, Kevin Valencia, Jude N. Owiredu
Publikováno v:
Oncotarget
// Dong Han 1 , Shuai Gao 1, 2 , Kevin Valencia 1 , Jude Owiredu 1 , Wanting Han 1 , Eric de Waal 3 , Jill A. Macoska 1 , Changmeng Cai 1, 2 1 Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts 02125, US
Autor:
Dong Han, Changmeng Cai, Susan Patalano, Wanting Han, Hansen H. He, Jude N. Owiredu, Jill A. Macoska, Sujun Chen, Shuai Gao
Publikováno v:
Cancer Research. 79:3482-3482
Prostate cancer (PCa) is one of the most common cancers in men globally. While the initiation and development of PCa depend on the activity of androgen receptor (AR), a ligand-dependent transcription factor nuclear receptor, loss of expressions of th
Autor:
Shuai Gao, Jude N. Owiredu, Steven P. Balk, Housheng Hansen He, Changmeng Cai, Sujun Chen, Wanting Han, Dong Han
Publikováno v:
Cancer Research. 79:923-923
Androgen receptor (AR) plays a critical function in driving prostate cancer (PCa) development and androgen deprivation therapy (ADT) is standard of care in treating PCa patients. Although patients generally response well, the cancer eventually relaps
Publikováno v:
Cancer Research. 77:4476-4476
Background: The standard treatment for prostate cancer (PCa) is androgen deprivation therapy (ADT) that blocks AR transcriptional activity, which is responsible to the initiation and progression of PCa. However, ADT invariably leads to the castration